Gene: IRAK4
Official Full Name: interleukin 1 receptor associated kinase 4provided by HGNC
Gene Summary: This gene encodes a kinase that activates NF-kappaB in both the Toll-like receptor (TLR) and T-cell receptor (TCR) signaling pathways. The protein is essential for most innate immune responses. Mutations in this gene result in IRAK4 deficiency and recurrent invasive pneumococcal disease. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO11060 | IRAK4 Knockout cell line (HeLa) | Human | IRAK4 | 1:3~1:6 | Negative | Online Inquiry |
KO11061 | IRAK4 Knockout cell line (HCT 116) | Human | IRAK4 | 1:2~1:4 | Negative | Online Inquiry |
KO11062 | IRAK4 Knockout cell line (HEK293) | Human | IRAK4 | 1:3~1:6 | Negative | Online Inquiry |
KO11063 | IRAK4 Knockout cell line (A549) | Human | IRAK4 | 1:3~1:4 | Negative | Online Inquiry |
IRAK4 Gene Knockout Cell Lines are state-of-the-art research tools specifically designed to study the role of the IRAK4 gene in innate immunity and various inflammatory diseases. These cell lines are engineered to create a complete knockout of the IRAK4 gene, which encodes a key kinase involved in the signaling pathways of Toll-like receptors (TLRs) and the interleukin-1 receptor (IL-1R). As such, these knockout models can effectively facilitate the investigation of IRAK4's function in various cellular responses, including cytokine production, cell proliferation, and apoptosis.
The key function of IRAK4 is to mediate signaling cascades that activate downstream inflammatory responses. In response to pathogen-associated molecular patterns (PAMPs), IRAK4 is recruited to receptors leading to the activation of the NF-κB pathway, critical for the immune response. By utilizing IRAK4 knockout cell lines, researchers can dissect the specific contributions of IRAK4 in these pathways, thus illuminating its role in disease mechanisms, including autoimmune disorders and cancer.
From a scientific perspective, these knockout cell lines are invaluable in both basic research and clinical settings. Their applications extend to drug discovery, where understanding IRAK4 interaction could lead to the development of novel therapeutics targeting inflammatory diseases and sepsis. Moreover, in the realm of personalized medicine, such models can provide insights into individual patient responses to treatment based on their unique IRAK4 signaling profiles.
What sets IRAK4 Gene Knockout Cell Lines apart from other available options is their validation and reliability, ensuring that researchers achieve consistent results. Moreover, these cell lines can be readily integrated into existing experimental protocols, significantly streamlining research workflows. Researchers and clinicians benefit from having access to a robust platform that not only enhances scientific understanding but also accelerates the translation of findings into therapeutic applications.
Our company specializes in offering advanced biological reagents and tools, including these knockout cell lines, drawing on years of expertise in molecular genetics and cell biology. We are committed to empowering researchers and clinicians in their pursuit of innovative solutions to tackle complex biological questions and develop effective therapies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.